nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ACKNOWLEDGEMENTS
|
|
|
2006 |
24 |
S3 |
p. xiii- 1 p. |
artikel |
2 |
Chapter 7: Achievements and limitations of cervical cytology screening
|
Kitchener, Henry C. |
|
2006 |
24 |
S3 |
p. S63-S70 8 p. |
artikel |
3 |
Chapter 22: Assuring the quality, safety and efficacy of HPV vaccines: The scientific basis of regulatory expectations pre- and post-licensure
|
Wood, David |
|
2006 |
24 |
S3 |
p. S187-S192 6 p. |
artikel |
4 |
Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease
|
Lacey, Charles J.N. |
|
2006 |
24 |
S3 |
p. S35-S41 7 p. |
artikel |
5 |
Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses
|
Arbyn, Marc |
|
2006 |
24 |
S3 |
p. S78-S89 12 p. |
artikel |
6 |
Chapter 19: Cost-effectiveness of cervical cancer screening
|
Goldie, Sue J. |
|
2006 |
24 |
S3 |
p. S164-S170 7 p. |
artikel |
7 |
Chapter 13: Current findings from prophylactic HPV vaccine trials
|
Koutsky, Laura A. |
|
2006 |
24 |
S3 |
p. S114-S121 8 p. |
artikel |
8 |
Chapter 25: Education, training, and communication for HPV vaccines
|
Sherris, Jacqueline |
|
2006 |
24 |
S3 |
p. S210-S218 9 p. |
artikel |
9 |
Chapter 6: Epidemiology and transmission dynamics of genital HPV infection
|
Burchell, Ann N. |
|
2006 |
24 |
S3 |
p. S52-S61 10 p. |
artikel |
10 |
Chapter 1: HPV in the etiology of human cancer
|
Muñoz, Nubia |
|
2006 |
24 |
S3 |
p. S1-S10 10 p. |
artikel |
11 |
Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases
|
Clifford, Gary |
|
2006 |
24 |
S3 |
p. S26-S34 9 p. |
artikel |
12 |
Chapter 14: HPV vaccine introduction in industrialized countries
|
Wright, Thomas C. |
|
2006 |
24 |
S3 |
p. S122-S131 10 p. |
artikel |
13 |
Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts
|
Wright, Thomas C. |
|
2006 |
24 |
S3 |
p. S251-S261 11 p. |
artikel |
14 |
Chapter 11: HPV vaccines: Commercial Research & Development
|
Inglis, Stephen |
|
2006 |
24 |
S3 |
p. S99-S105 7 p. |
artikel |
15 |
Chapter 16: HPV vaccines in immunocompromised women and men
|
Palefsky, Joel M. |
|
2006 |
24 |
S3 |
p. S140-S146 7 p. |
artikel |
16 |
Chapter 15: HPV vaccine use in the developing world
|
Kane, Mark A. |
|
2006 |
24 |
S3 |
p. S132-S139 8 p. |
artikel |
17 |
Chapter 26: Innovative financing mechanisms to accelerate the introduction of HPV vaccines in developing countries
|
Batson, Amie |
|
2006 |
24 |
S3 |
p. S219-S225 7 p. |
artikel |
18 |
Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays—an update
|
Pagliusi, Sonia R. |
|
2006 |
24 |
S3 |
p. S193-S200 8 p. |
artikel |
19 |
Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination
|
Franco, Eduardo L. |
|
2006 |
24 |
S3 |
p. S171-S177 7 p. |
artikel |
20 |
Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer
|
Franco, Eduardo L. |
|
2006 |
24 |
S3 |
p. S242-S249 8 p. |
artikel |
21 |
Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes
|
Garnett, Geoffrey P. |
|
2006 |
24 |
S3 |
p. S178-S186 9 p. |
artikel |
22 |
Chapter 10: New dimensions in cervical cancer screening
|
Cuzick, Jack |
|
2006 |
24 |
S3 |
p. S90-S97 8 p. |
artikel |
23 |
Chapter 12: Prophylactic HPV vaccines: Underlying mechanisms
|
Stanley, Margaret |
|
2006 |
24 |
S3 |
p. S106-S113 8 p. |
artikel |
24 |
Chapter 24: Psychosocial aspects of vaccine acceptability
|
Zimet, Gregory D. |
|
2006 |
24 |
S3 |
p. S201-S209 9 p. |
artikel |
25 |
Chapter 18: Public health policy for cervical cancer prevention: The role of decision science, economic evaluation, and mathematical modeling
|
Goldie, Sue J. |
|
2006 |
24 |
S3 |
p. S155-S163 9 p. |
artikel |
26 |
Chapter 27: Research needs following initial licensure of virus-like particle HPV vaccines
|
Hildesheim, Allan |
|
2006 |
24 |
S3 |
p. S227-S232 6 p. |
artikel |
27 |
Chapter 8: Screening for cervical cancer in developing countries
|
Denny, Lynette |
|
2006 |
24 |
S3 |
p. S71-S77 7 p. |
artikel |
28 |
Chapter 17: Second generation HPV vaccines to prevent cervical cancer
|
Schiller, John T. |
|
2006 |
24 |
S3 |
p. S147-S153 7 p. |
artikel |
29 |
Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries
|
Lehtinen, Matti |
|
2006 |
24 |
S3 |
p. S233-S241 9 p. |
artikel |
30 |
Chapter 2: The burden of HPV-related cancers
|
Parkin, D. Maxwell |
|
2006 |
24 |
S3 |
p. S11-S25 15 p. |
artikel |
31 |
Chapter 5: Updating the natural history of HPV and anogenital cancer
|
Moscicki, Anna-Barbara |
|
2006 |
24 |
S3 |
p. S42-S51 10 p. |
artikel |
32 |
Disclosure of Financial Support
|
|
|
2006 |
24 |
S3 |
p. S263- 1 p. |
artikel |
33 |
Editorial Board/Aims and Scope
|
|
|
2006 |
24 |
S3 |
p. CO2- 1 p. |
artikel |
34 |
List of Contributors
|
|
|
2006 |
24 |
S3 |
p. vii-ix nvt p. |
artikel |
35 |
Perspectives of contemporary papillomavirus research
|
zur Hausen, Harald |
|
2006 |
24 |
S3 |
p. iii-iv nvt p. |
artikel |
36 |
Preface
|
Bosch, F. Xavier |
|
2006 |
24 |
S3 |
p. v-vi nvt p. |
artikel |